This was the conclusion of a round table discussion held 7 March in Riga, Latvia. Participants were regional and national authorities, the Nordic Council of Ministers, industries, universities and clusters within life sciences and biotechnology.
The round table was organised by the Latvian Association of Biotechnology and ScanBalt as part of an EU funded project “Bridge-BSR” which over the next 3 years shall strengthen bridges between academic research and SME´s in order to promote commercialisation and job creation. Other partners are Steinbeis Team Northeast, Medicon Valley Alliance, Estonian Biotech Association, IPPT-Pan, BioForum Oulu and BioCon Valley.
The coordinator of Bridge-BSR, General secretary Peter Frank, ScanBalt, says “We look forward to establish cross-border support structures for SME´s in the Baltic Sea Region. They need easier access to private-public financing and they need support to participate in EU-programmes. We hope to initiate successfully the necessary structures and intend to create a widely accepted joint innovation plan.
The plan will focus on SME´s within life sciences in the Baltic Sea Region – ScanBalt BioRegion. In addition we will reinforce our efforts to integrate management of Intellectual Properties in academic research in order to promote exploitation. However to be successful requires strong regional clusters throughout the region, this is a prerequisite. We work to promote this development.”
Elise Kvarnstroem | alfa
Microtechnology industry is hiring – positive developments of past years continue
09.04.2018 | IVAM Fachverband für Mikrotechnik
RWI/ISL-Container Throughput Index with minor decline on a high overall level
20.03.2018 | RWI – Leibniz-Institut für Wirtschaftsforschung
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
14.12.2018 | Power and Electrical Engineering
14.12.2018 | Physics and Astronomy
14.12.2018 | Physics and Astronomy